Showing results (181-190 of 281) with videos related to
Sort By:
Pageof 29
Digestive Diseases and Sciences|October 1, 1992
Significance and regulation of gastric secretion of platelet-activating factor (PAF-acether) in manI Sobhani, Y Denizot, C Vissuzaine, et al.Gastroenterologie Clinique Et Biologique|January 1, 1994
[Stenosing esophagitis in Zollinger-Ellison syndrome]G Cadiot, C Hélie, T Vallot, et al.Infection and Immunity|March 1, 1995
Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccinesL Lissolo, G Maitre-Wilmotte, P Dumas, et al.La Nouvelle Presse Medicale|April 10, 1982
[Hyperparathyroidism associated with Zollinger-Ellison syndrome. 4 cases (author's transl)]D Rigaud, P Bauer, P Hervoir, et al.Gastroenterologie Clinique Et Biologique|December 17, 1998
[Effectiveness and safety of lansoprazole in the treatment of Zollinger-Ellison syndrome. First six months of treatment]D Pospaï, G Cadiot, S Forestier, et al.British Journal of Clinical Pharmacology|February 1, 1996
Lanreotide inhibits human jejunal secretion induced by prostaglandin E1 in healthy volunteersI Sobhani, E René, A Ramdani, et al.NMR in Biomedicine|July 7, 2011
Towards optimized MR thermometry of the human heart at 3TS Hey, A Cernicanu, B D de Senneville, et al.Pacing and Clinical Electrophysiology : PACE|January 5, 2001
Concealed left pulmonary vein potentials unmasked by left atrial stimulationM Hocini, D C Shah, P Jaïs, et al.Molecular Vision|December 23, 2008
Differential regulation of Dlg1, Scrib, and Lgl1 expression in a transgenic mouse model of ocular cancerV Vieira, G de la Houssaye, E Lacassagne, et al.Gastroenterology|April 1, 1989
Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatmentT Lehy, M Mignon, G Cadiot, et al.Pageof 29